BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34391746)

  • 1. MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas.
    Shetty S; Habeeb O; Rivera C; Astbury C; Przybycin C; Joehlin-Price AS
    Hum Pathol; 2021 Nov; 117():42-50. PubMed ID: 34391746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of MDM2 and Loss of p16 Expression: Do They Have a Role in Malignant Transformation of Ovarian Brenner Tumor?
    Wang L; Allison D; Shukla PS
    Am J Clin Pathol; 2020 Jun; 154(1):133-141. PubMed ID: 32322877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
    Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
    Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology.
    Pfarr N; Darb-Esfahani S; Leichsenring J; Taube E; Boxberg M; Braicu I; Jesinghaus M; Penzel R; Endris V; Noske A; Weichert W; Schirmacher P; Denkert C; Stenzinger A
    Genes Chromosomes Cancer; 2017 Oct; 56(10):758-766. PubMed ID: 28639280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
    Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison.
    Austin RM; Norris HJ
    Int J Gynecol Pathol; 1987; 6(1):29-39. PubMed ID: 3570630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
    Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
    Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
    Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
    Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
    Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
    Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian Low-grade Basaloid Carcinoma Arising in Brenner Tumor: A New Variant of Malignant Brenner Tumor.
    McGinn B; Lemaire AS; McCluggage WG
    Int J Gynecol Pathol; 2022 May; 41(3):276-284. PubMed ID: 34015796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearance of Upper Urinary Tract Urothelial Carcinoma after Treatment of a Borderline Brenner Tumor: Case Report and Literature Review.
    Aoun F; Kourie HR; Sirtaine N; Hawaux E
    Oncol Res Treat; 2015; 38(7-8):379-81. PubMed ID: 26278583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant Brenner tumor and transitional cell carcinoma of the ovary].
    Guo LN; Tang MY
    Zhonghua Bing Li Xue Za Zhi; 1990 Sep; 19(3):209-11. PubMed ID: 2279315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transitional cell tumors:malignant Brenner tumor and transitional cell carcinoma of the ovary].
    Ianev N; Ivanova R; Gorchev G; Tsvetkov Ch; Veselinova T; Strateva D
    Akush Ginekol (Sofiia); 2007; 46 Suppl 2():20-22. PubMed ID: 18219757
    [No Abstract]   [Full Text] [Related]  

  • 19. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
    Ali RH; Seidman JD; Luk M; Kalloger S; Gilks CB
    Int J Gynecol Pathol; 2012 Nov; 31(6):499-506. PubMed ID: 23018212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant Brenner tumor and transitional cell ovarian carcinoma--description of two cases].
    Ivanova R; Veselinova T; Marinov E; Ianev N; Tsvetkov Ch; Gorchev G
    Akush Ginekol (Sofiia); 2001; 42(2):31-3. PubMed ID: 11799755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.